Plotkin's Vaccines 8th Edition

  • A paraître
Plotkin's Vaccines 8

Plotkin's Vaccines 8th Edition

  • A paraître
From the latest vaccination evidence, recommendations, and protocols to new vaccine development and the use of vaccines, "Plotkin's Vaccines, 8th Edition", covers every aspect of vaccination. 

Lire la suite keyboard_arrow_right

Pages 1734
Taille 27.62 X 21.59
Type Relié
ISBN 9780323790581

Description détaillée : Plotkin's Vaccines 8th Edition

Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development.

Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines" is a must-have reference for current, authoritative information in this fast-moving field.

What is the content of "Plotkin's Vaccines 8th edition" ?

  • Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization.

  • Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines.

  • Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality.

  • Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.

  • Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.

  • Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues.

  • Analyzes the cost-benefit and cost-effectiveness of different vaccine options.

  • Helps you clearly visualize concepts and objective data through an abundance of tables and figures.

  • Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Who are the authors of "Plotkin's Vaccines 8th edition" ?

Walter A. Orenstein, MD, DSc (HON), Professor of Medicine and Pediatrics, and Global Health, Emory University; Associate Director, Emory Vaccine Center, Atlanta GA; Bill & Melinda Gates Foundation, Seattle, WA; Former Director, National Immunization Program, Centers for Disease Control and Prevention, Atlanta GA ; USA

Paul A. Offit, MD, Chief, Division of Infectious Diseases, Director, Vaccine Education Center, The Children's Hospital of Philadelphia; Professor of Pediatrics, Maurice R. Hilleman Professor of Vaccinology, Perelman School of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; USA

Kathryn M. Edwards, MD, Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics, Professor of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

Stanley A. Plotkin, MD, Emeritus Professor of Pediatrics, University of Pennsylvania, Emeritus Professor, Wistar Institute, Former Chief, Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA; Former Medical and Scientific Director, Pasteur Merieux Connaught (now Sanofi Pasteur), Marnes-la-Coquette, France

Sommaire : Plotkin's Vaccines 8th Edition

Section 1: General Aspects of Vaccination
1A short history of vaccination
2Vaccine immunology
3Non-specific effects of Vaccines
4Correlates of protection
5The vaccine industry
6Vaccine manufacturing
7Evolution of adjuvants across the centuries
8Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
9Passive immunization
Section 2: Licenced Vaccines and Vaccines in Development
10General immunization practices
11Human Adenovirus vaccines
12Anthrax vaccines
13EMERGING Diseases and Emerging VACCINES (Military)
14Cancer vaccines
15Cholera vaccines
16Combination vaccines
17Coronavirus
18Cytomegalovirus vaccines
19Dengue vaccines
20Diarrhea caused by bacteria
21Diphtheria toxoid
22Ebola vaccines
23Enterovirus
24Epstein-Barr virus vaccines
25Haemophilus influenzae type b vaccines
26Hepatitis A vaccines
27Hepatitis B vaccines
28Hepatitis C vaccines
29Hepatitis E vaccines
30Herpes simplex virus vaccines
31Human immunodeficiency virus vaccines
32Human papillomavirus vaccines
33Inactivated influenza vaccines
34Influenza vaccine?live
35Japanese encephalitis vaccines
36Lyme disease vaccines
37Malaria vaccines
38Measles vaccine
39Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines
40Meningococcal Capsular B Vaccines
41Mumps vaccines
42Noninfectious disease vaccines
43Norovirus
44Norovirus
44Parasitic disease vaccines
45Pertussis vaccines
46Plague vaccines
47Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
48Pneumococcal polysaccharide vaccines
49Poliovirus vaccine?inactivated
50Poliovirus vaccine?live
51Rabies vaccines
52Respiratory syncytial virus vaccines
53Rotavirus vaccines
54Rubella vaccine
55Smallpox and vaccinia
56Staphylococcus aureus vaccines
57Streptococcus group A vaccines
58Streptococcus group B vaccines
59Tetanus toxoid
60Tick-borne encephalitis virus vaccines
61Tuberculosis vaccines
62Typhoid fever vaccines
63Varicella vaccine
64Yellow fever vaccine
65Zika vaccine
66Zoster vaccine
67Technologies for making new vaccines
68Section 3: New Technologies
68The development of gene-based vectors for immunization
69Technologies to Improve Immunization
70Vaccination of immunocompromised hosts
71Section 4: Vaccination in Special Groups
71Vaccines for international travel
72Vaccines for health care personnel
73Vaccination of pregnant women
74Vaccination of pregnant women
74Immunization in the United States
75Immunization in Europe
76Section 5: Public Health and Regulatory Issues
76Immunization in the Asia-Pacific region
77Immunization in developing countries
78Community Protection
79Economic analyses of vaccine policies
80Regulation and testing of vaccines IN THE US
81Regulation of vaccines in Europe
82Regulation of vaccines in low and middle-income countries
83Vaccine safety
84Vaccine hesitancy
85Legal issues
86Ethics
Appendix
Foreword

328,91 €

Bientôt disponible

Expédition dès parution

328,91 €
Alerte disponibilité

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

3D Secure

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email